Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of dexamethasone plus paclitaxel and
gemcitabine in treating patients with platinum-resistant recurrent ovarian cancer.